Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2010622 Target Snapshot

Leucine-rich repeat serine/threonine-protein kinase 2 · SINGLE PROTEIN · Mus musculus

58Compounds
55Assays
0Approved Drugs
59.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q5S006. Use UniProt Q5S006 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q5S006 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Leucine-rich repeat serine/threonine-protein kinase 2 as ChEMBL target CHEMBL2010622, mapped to UniProt Q5S006. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Leucine-rich repeat serine/threonine-protein kinase 2
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL2010622
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q5S006
Leucine-rich repeat serine/threonine-protein kinase 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Leucine-rich repeat serine/threonine-protein kinase 2 is the right protein anchor across sources, using UniProt Q5S006 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLeucine-rich repeat serine/threonine-protein kinase 2
UniProt AccessionQ5S006
Component TypeProtein
Sequence Length2527 aa

Leucine-rich repeat serine/threonine-protein kinase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Leucine-rich repeat serine/threonine-protein kinase 2, mapped to UniProt Q5S006. Sequence length is 2527 aa.

Mapped IDQ5S006
Review nameLeucine-rich repeat serine/threonine-protein kinase 2
OrganismMus musculus
Assay Mix

Activity Type Distribution

IC5013.0
EC5046.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4098877 9.1 IC50 0.8 Preclinical
CHEMBL5087055 7.96 IC50 11.0 Preclinical
CHEMBL5092087 7.66 IC50 22.0 Preclinical
CHEMBL4098877 7.52 EC50 30.0 Preclinical
CHEMBL5437266 6.72 IC50 190.0 Preclinical
CHEMBL5170238 6.58 EC50 260.0 Preclinical
CHEMBL5181966 6.55 EC50 280.0 Preclinical
CHEMBL5177578 6.54 EC50 290.0 Preclinical
CHEMBL5173029 6.47 EC50 340.0 Preclinical
CHEMBL5172291 6.41 EC50 390.0 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
10
5.5
10
6.0
4
6.5
0
7.0
5
7.5
6
8.0
1
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

55
Total Assays
41
Tested Compounds
2
Assay Types
Binding — 28 assays, 41 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 21 38 5.6
assay format 3 0
organism-based format 2 2 7.8
single protein format 1 1 6.7
tissue-based format 1 0
Functional — 27 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 27 1 8.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine